NUVIS’ second generation reduces the number of optical elements by 60 percent and boosts image quality to 4K. The device is also faster, and will cost less to manufacture. It is battery operated, cordless and FDA 501(k) cleared.
“The demand we have seen for NUVIS far exceeds our current manufacturing capacity, so the efficiencies the Gen II NUVIS affords will greatly aid in shortening production time and costs,” Brad Sharp, Integrated Endoscopy’s CEO, said in the release. “With a global market of over 1.5 million units per month, increasing our manufacturing capacity will be a major focus for the company moving forward.”
